Editorial: Revival of gliadin antibodies in the diagnostic work-up of celiac disease

Journal of Clinical Gastroenterology

Volumn 44, Issue 3, 2010, Pages 159-160

  Collin, Pekka ^a   Mäki, Markku ^a   Kaukinen, Katri ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; ANTIBODY; GLIADIN;

BIOPSY; CELIAC DISEASE; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GLUTEN FREE DIET; HUMAN; IMMUNOFLUORESCENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; IMMUNOLOGY; NOTE; UNITED STATES;

ANTIBODIES; CELIAC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIADIN; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 77649327649     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181cb4245     Document Type: Editorial

References (13)

1. Murray JA, Van Dyke C, Plevak MF, et al. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol. 2003; 1:19-27.
2. Virta L, Kaukinen K, Collin P. Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol. 2009;44:933-938.
3. Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? Do sensitivity and specificity vary in different populations? Gastroenterology. 2005;128:S25-S32.
4. Salmi TT, Collin P, Reunala T, et al. Diagnostic methods beyond conventional histology in coeliac disease diagnosis. Dig Liver Dis. 2009. In press. doi:10.1016/j.dld.2009.04.004.
5. Dickey W, Hughes DF, McMillan SA. Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery. Am J Gastroenterol. 2000;95:712-714.
6. Kaukinen K, Sulkanen S, Mäki M, et al. IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol. 2002;14:311-315.
7. Rostami K, Kerckhaert J, Tiemessen R, et al. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 1999;94:888-894.
8. Collin P, Kaukinen K, Vogelsang H, et al. Anti-endomysial and anti-human recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol. 2005;17:85-91.
9. Volta U, Granito A, Parisi C, et al. Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol. 2010;44:185-190.
10. Collin P, Kaukinen K, Välimäki M, et al. Endocrinological disorders and celiac disease. Endocr Rev. 2002;23:464-483.
11. Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptide (DGP) antibody and tissue transglutaminase (tTG) antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther. 2010;31:73-81.
12. Kaukinen K, Collin P, Laurila K, et al. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol. 2007;42:1428-1433.
13. Volta U, Granito A, Fiorini E, et al. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci. 2008;53:1582-1588.